Clinical Trial Kits Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,995	250 Pages	Fairfield Market Research	December, 2023	FCSL18382121

Best Price Guarantee
Price	from $4,995
Length	250 Pages
Publisher	Fairfield Market Research
Published Date	December, 2023
SKU	FCSL18382121

Clinical Trial Kits Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

The global clinical trial kits market, valued at approximately US$ 1.7 billion in 2024, is expected to exhibit remarkable growth and reach a valuation of US$ 4.3 billion by the end of 2031. This surge in market value is attributed to the increasing number of clinical trials conducted worldwide.

Influence of Direct-to-Patient (DtP) Clinical Trials on the Clinical Trial Kits Market

Direct-to-Patient (DtP) clinical trials have emerged as a cost-effective and convenient alternative to traditional clinical trials, motivating pharmaceutical and drug manufacturing companies to embrace them. DtP clinical trials involve collecting patient samples from their homes and delivering trial drugs directly to their doorstep. The integrity of trial kits is paramount, as damaged trial drugs can have significant consequences. The growing demand for DtP clinical trials is a major driver propelling the growth of the clinical trial kits market.

Challenges Restraining Market Growth

One of the key challenges in clinical trials is the transportation of samples and medicines under precise temperature conditions. Ensuring the proper delivery of samples to testing facilities and delivering drugs to patients at the right time is crucial. Some samples and medicines require strict temperature control, making the use of temperature-controlled shipping containers more expensive than standard shippers. Additionally, there is a higher likelihood of errors when individuals are involved in sample collection. These factors are expected to restrain the growth of the clinical trial kits market.

Regional Insights: Clinical Trial Kits Demand in North America

North America is witnessing a surge in the demand for phase III clinical studies, driven by the increasing incidence of cancer. Moreover, pharmaceutical and drug development companies in the region are transitioning towards virtual and decentralized clinical trials, which will further boost the demand for clinical trial kits in North America in the coming years.

Country-Wise Insights

U.S. Clinical Trial Kits Market Analysis

The United States stands out as a significant hub for clinical trials, with approximately 32% of all registered clinical studies taking place in the country, according to ClinicalTrials.gov. The rapid adoption of decentralized clinical trials is a major driver for the clinical trial kits market in the U.S.

China Clinical Trial Kits Market Analysis

The country has developed a robust clinical trial infrastructure with skilled experts and an extensive network of experienced therapeutic professionals. Additionally, the large pool of eligible patients for clinical trials is contributing to market growth. The clinical trial kits market in China is expected to create an absolute dollar opportunity over the period from 2024 to 2031.

U.K. Clinical Trial Kits Market Analysis

The U.K. market is expected to experience substantial growth from 2024 to 2031, and a significant absolute dollar opportunity.

Japan Clinical Trial Kits Market Analysis

Japan is poised to see robust growth, resulting in a substantial absolute dollar opportunity during forecast period.

Competitive Landscape

Currently, clinical trial kit manufacturers are actively expanding their manufacturing facilities to increase production capacity. Key companies operating in the clinical trial kits market include Azenta Life Sciences, Q2 Solutions, Patheon (Thermo Fisher Scientific), LabCorp Drug Development, Charles River Laboratories, LabConnect, Almac Group, Precision Medicine Group, Cerba Research, Alpha Laboratories Ltd, Marken SAS, and Clinigen.

Key Segments Covered in Clinical Trial Kits Industry Survey

By Service Type:
• Kitting Solutions
Drugs Kits
Sample Collection Kits
• Logistics
Transportation
Warehousing & Storage
Other Logistics

By Phase:
• Phase I
• Phase II
• Phase III
• Phase IV

By Region:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.

1. Executive Summary: 1.1. Global Clinical Trial Kits Market Snapshot; 1.2. Future Projections; 1.3. Key Market Trends; 1.4. Regional Snapshot, by Value, 2023; 1.5. Analyst Recommendations
2. Market Overview: 2.1. Market Definitions and Segmentations; 2.2. Market Dynamics; 2.2.1. Drivers; 2.2.2. Restraints; 2.2.3. Market Opportunities; 2.3. Value Chain Analysis; 2.4. Porter’s Five Forces Analysis; 2.5. COVID-19 Impact Analysis; 2.5.1. Supply; 2.5.2. Demand; 2.6. Impact of Ukraine-Russia Conflict; 2.7. Economic Overview; 2.7.1. World Economic Projections; 2.8. PESTLE Analysis
3. Global Clinical Trial Kits Market Outlook, 2018 – 2031: 3.1. Global Clinical Trial Kits Market Outlook, by Service Type, Value (US$ Bn), 2018 – 2031; 3.1.1. Key Highlights; 3.1.1.1. Kitting Solutions; 3.1.1.2. Drugs Kits; 3.1.1.3. Sample Collection Kits; 3.1.1.4. Logistics; 3.1.1.5. Transportation; 3.1.1.6. Warehousing & Storage; 3.1.1.7. Other Logistics; 3.2. Global Clinical Trial Kits Market Outlook, by Phase, Value (US$ Bn), 2018 – 2031; 3.2.1. Key Highlights; 3.2.1.1. Phase I; 3.2.1.2. Phase II; 3.2.1.3. Phase III; 3.2.1.4. Phase IV; 3.3. Global Clinical Trial Kits Market Outlook, by Region, Value (US$ Bn), 2018 – 2031; 3.3.1. Key Highlights; 3.3.1.1. North America; 3.3.1.2. Europe; 3.3.1.3. Asia Pacific; 3.3.1.4. Latin America; 3.3.1.5. Middle East & Africa
4. North America Clinical Trial Kits Market Outlook, 2018 – 2031: 4.1. North America Clinical Trial Kits Market Outlook, by Service Type, Value (US$ Bn), 2018 – 2031; 4.1.1. Key Highlights; 4.1.1.1. Kitting Solutions; 4.1.1.2. Drugs Kits; 4.1.1.3. Sample Collection Kits; 4.1.1.4. Logistics; 4.1.1.5. Transportation; 4.1.1.6. Warehousing & Storage; 4.1.1.7. Other Logistics; 4.2. North America Clinical Trial Kits Market Outlook, by Phase, Value (US$ Bn), 2018 – 2031; 4.2.1. Key Highlights; 4.2.1.1. Phase I; 4.2.1.2. Phase II; 4.2.1.3. Phase III; 4.2.1.4. Phase IV; 4.2.2. BPS Analysis/Market Attractiveness Analysis; 4.3. North America Clinical Trial Kits Market Outlook, by Country, Value (US$ Bn), 2018 – 2031; 4.3.1. Key Highlights; 4.3.1.1. U.S. Clinical Trial Kits Market by Service Type, Value (US$ Bn), 2018 – 2031; 4.3.1.2. U.S. Clinical Trial Kits Market by Phase, Value (US$ Bn), 2018 – 2031; 4.3.1.3. Canada Clinical Trial Kits Market by Service Type, Value (US$ Bn), 2018 – 2031; 4.3.1.4. Canada Clinical Trial Kits Market by Phase, Value (US$ Bn), 2018 – 2031; 4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Clinical Trial Kits Market Outlook, 2018 – 2031: 5.1. Europe Clinical Trial Kits Market Outlook, by Service Type, Value (US$ Bn), 2018 – 2031; 5.1.1. Key Highlights; 5.1.1.1. Kitting Solutions; 5.1.1.2. Drugs Kits; 5.1.1.3. Sample Collection Kits; 5.1.1.4. Logistics; 5.1.1.5. Transportation; 5.1.1.6. Warehousing & Storage; 5.1.1.7. Other Logistics; 5.2. Europe Clinical Trial Kits Market Outlook, by Phase, Value (US$ Bn), 2018 – 2031; 5.2.1. Key Highlights; 5.2.1.1. Phase I; 5.2.1.2. Phase II; 5.2.1.3. Phase III; 5.2.1.4. Phase IV; 5.2.2. BPS Analysis/Market Attractiveness Analysis; 5.3. Europe Clinical Trial Kits Market Outlook, by Country, Value (US$ Bn), 2018 – 2031; 5.3.1. Key Highlights; 5.3.1.1. Germany Clinical Trial Kits Market by Service Type, Value (US$ Bn), 2018 – 2031; 5.3.1.2. Germany Clinical Trial Kits Market by Phase, Value (US$ Bn), 2018 – 2031; 5.3.1.3. U.K. Clinical Trial Kits Market by Service Type, Value (US$ Bn), 2018 – 2031; 5.3.1.4. U.K. Clinical Trial Kits Market by Phase, Value (US$ Bn), 2018 – 2031; 5.3.1.5. France Clinical Trial Kits Market by Service Type, Value (US$ Bn), 2018 – 2031; 5.3.1.6. France Clinical Trial Kits Market by Phase, Value (US$ Bn), 2018 – 2031; 5.3.1.7. Italy Clinical Trial Kits Market by Service Type, Value (US$ Bn), 2018 – 2031; 5.3.1.8. Italy Clinical Trial Kits Market by Phase, Value (US$ Bn), 2018 – 2031; 5.3.1.9. Turkey Clinical Trial Kits Market by Service Type, Value (US$ Bn), 2018 – 2031; 5.3.1.10. Turkey Clinical Trial Kits Market by Phase, Value (US$ Bn), 2018 – 2031; 5.3.1.11. Russia Clinical Trial Kits Market by Service Type, Value (US$ Bn), 2018 – 2031; 5.3.1.12. Russia Clinical Trial Kits Market by Phase, Value (US$ Bn), 2018 – 2031; 5.3.1.13. Rest of Europe Clinical Trial Kits Market by Service Type, Value (US$ Bn), 2018 – 2031; 5.3.1.14. Rest of Europe Clinical Trial Kits Market by Phase, Value (US$ Bn), 2018 – 2031; 5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Clinical Trial Kits Market Outlook, 2018 – 2031: 6.1. Asia Pacific Clinical Trial Kits Market Outlook, by Service Type, Value (US$ Bn), 2018 – 2031; 6.1.1. Key Highlights; 6.1.1.1. Kitting Solutions; 6.1.1.2. Drugs Kits; 6.1.1.3. Sample Collection Kits; 6.1.1.4. Logistics; 6.1.1.5. Transportation; 6.1.1.6. Warehousing & Storage; 6.1.1.7. Other Logistics; 6.2. Asia Pacific Clinical Trial Kits Market Outlook, by Phase, Value (US$ Bn), 2018 – 2031; 6.2.1. Key Highlights; 6.2.1.1. Phase I; 6.2.1.2. Phase II; 6.2.1.3. Phase III; 6.2.1.4. Phase IV; 6.2.2. Others BPS Analysis/Market Attractiveness Analysis; 6.3. Asia Pacific Clinical Trial Kits Market Outlook, by Country, Value (US$ Bn), 2018 – 2031; 6.3.1. Key Highlights; 6.3.1.1. China Clinical Trial Kits Market by Service Type, Value (US$ Bn), 2018 – 2031; 6.3.1.2. China Clinical Trial Kits Market by Phase, Value (US$ Bn), 2018 – 2031; 6.3.1.3. Japan Clinical Trial Kits Market by Service Type, Value (US$ Bn), 2018 – 2031; 6.3.1.4. Japan Clinical Trial Kits Market by Phase, Value (US$ Bn), 2018 – 2031; 6.3.1.5. South Korea Clinical Trial Kits Market by Service Type, Value (US$ Bn), 2018 – 2031; 6.3.1.6. South Korea Clinical Trial Kits Market by Phase, Value (US$ Bn), 2018 – 2031; 6.3.1.7. India Clinical Trial Kits Market by Service Type, Value (US$ Bn), 2018 – 2031; 6.3.1.8. India Clinical Trial Kits Market by Phase, Value (US$ Bn), 2018 – 2031; 6.3.1.9. Southeast Asia Clinical Trial Kits Market by Service Type, Value (US$ Bn), 2018 – 2031; 6.3.1.10. Southeast Asia Clinical Trial Kits Market by Phase, Value (US$ Bn), 2018 – 2031; 6.3.1.11. Rest of Asia Pacific Clinical Trial Kits Market by Service Type, Value (US$ Bn), 2018 – 2031; 6.3.1.12. Rest of Asia Pacific Clinical Trial Kits Market by Phase, Value (US$ Bn), 2018 – 2031; 6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Clinical Trial Kits Market Outlook, 2018 – 2031: 7.1. Latin America Clinical Trial Kits Market Outlook, by Service Type, Value (US$ Bn), 2018 – 2031; 7.1.1. Key Highlights; 7.1.1.1. Kitting Solutions; 7.1.1.2. Drugs Kits; 7.1.1.3. Sample Collection Kits; 7.1.1.4. Logistics; 7.1.1.5. Transportation; 7.1.1.6. Warehousing & Storage; 7.1.1.7. Other Logistics; 7.2. Latin America Clinical Trial Kits Market Outlook, by Phase, Value (US$ Bn), 2018 – 2031; 7.2.1.1. Phase I; 7.2.1.2. Phase II; 7.2.1.3. Phase III; 7.2.1.4. Phase IV; 7.2.2. BPS Analysis/Market Attractiveness Analysis; 7.3. Latin America Clinical Trial Kits Market Outlook, by Country, Value (US$ Bn), 2018 – 2031; 7.3.1. Key Highlights; 7.3.1.1. Brazil Clinical Trial Kits Market by Service Type, Value (US$ Bn), 2018 – 2031; 7.3.1.2. Brazil Clinical Trial Kits Market by Phase, Value (US$ Bn), 2018 – 2031; 7.3.1.3. Mexico Clinical Trial Kits Market by Service Type, Value (US$ Bn), 2018 – 2031; 7.3.1.4. Mexico Clinical Trial Kits Market by Phase, Value (US$ Bn), 2018 – 2031; 7.3.1.5. Argentina Clinical Trial Kits Market by Service Type, Value (US$ Bn), 2018 – 2031; 7.3.1.6. Argentina Clinical Trial Kits Market by Phase, Value (US$ Bn), 2018 – 2031; 7.3.1.7. Rest of Latin America Clinical Trial Kits Market by Service Type, Value (US$ Bn), 2018 – 2031; 7.3.1.8. Rest of Latin America Clinical Trial Kits Market by Phase, Value (US$ Bn), 2018 – 2031; 7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Clinical Trial Kits Market Outlook, 2018 – 2031: 8.1. Middle East & Africa Clinical Trial Kits Market Outlook, by Service Type, Value (US$ Bn), 2018 – 2031; 8.1.1. Key Highlights; 8.1.1.1. Kitting Solutions; 8.1.1.2. Drugs Kits; 8.1.1.3. Sample Collection Kits; 8.1.1.4. Logistics; 8.1.1.5. Transportation; 8.1.1.6. Warehousing & Storage; 8.1.1.7. Other Logistics; 8.2. Middle East & Africa Clinical Trial Kits Market Outlook, by Phase, Value (US$ Bn), 2018 – 2031; 8.2.1. Key Highlights; 8.2.1.1. Phase I; 8.2.1.2. Phase II; 8.2.1.3. Phase III; 8.2.1.4. Phase IV; 8.2.2. BPS Analysis/Market Attractiveness Analysis; 8.3. Middle East & Africa Clinical Trial Kits Market Outlook, by Country, Value (US$ Bn), 2018 – 2031; 8.3.1. Key Highlights; 8.3.1.1. GCC Clinical Trial Kits Market by Service Type, Value (US$ Bn), 2018 – 2031; 8.3.1.2. GCC Clinical Trial Kits Market by Phase, Value (US$ Bn), 2018 – 2031; 8.3.1.3. South Africa Clinical Trial Kits Market by Service Type, Value (US$ Bn), 2018 – 2031; 8.3.1.4. South Africa Clinical Trial Kits Market by Phase, Value (US$ Bn), 2018 – 2031; 8.3.1.5. Egypt Clinical Trial Kits Market by Service Type, Value (US$ Bn), 2018 – 2031; 8.3.1.6. Egypt Clinical Trial Kits Market by Phase, Value (US$ Bn), 2018 – 2031; 8.3.1.7. Nigeria Clinical Trial Kits Market by Service Type, Value (US$ Bn), 2018 – 2031; 8.3.1.8. Nigeria Clinical Trial Kits Market by Phase, Value (US$ Bn), 2018 – 2031; 8.3.1.9. Rest of Middle East & Africa Clinical Trial Kits Market by Service Type, Value (US$ Bn), 2018 – 2031; 8.3.1.10. Rest of Middle East & Africa Clinical Trial Kits Market by Phase, Value (US$ Bn), 2018 – 2031; 8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape: 9.1. Manufacturer vs by Phase Heatmap; 9.2. Company Market Share Analysis, 2023; 9.3. Competitive Dashboard; 9.4. Company Profiles; 9.4.1. Azenta Life Sciences; 9.4.1.1. Company Overview; 9.4.1.2. Product Portfolio; 9.4.1.3. Financial Overview; 9.4.1.4. Business Strategies and Development; 9.4.2. Q2 Solutions; 9.4.2.1. Company Overview; 9.4.2.2. Product Portfolio; 9.4.2.3. Financial Overview; 9.4.2.4. Business Strategies and Development; 9.4.3. Patheon; 9.4.3.1. Company Overview; 9.4.3.2. Product Portfolio; 9.4.3.3. Financial Overview; 9.4.3.4. Business Strategies and Development; 9.4.4. LabCorp drug development; 9.4.4.1. Company Overview; 9.4.4.2. Product Portfolio; 9.4.4.3. Financial Overview; 9.4.4.4. Business Strategies and Development; 9.4.5. Charles River Laboratories; 9.4.5.1. Company Overview; 9.4.5.2. Product Portfolio; 9.4.5.3. Financial Overview; 9.4.5.4. Business Strategies and Development; 9.4.6. LabConnect; 9.4.6.1. Company Overview; 9.4.6.2. Product Portfolio; 9.4.6.3. Financial Overview; 9.4.6.4. Business Strategies and Development; 9.4.7. Almac group; 9.4.7.1. Company Overview; 9.4.7.2. Product Portfolio; 9.4.7.3. Financial Overview; 9.4.7.4. Business Strategies and Development; 9.4.8. Precision medicine group; 9.4.8.1. Company Overview; 9.4.8.2. Product Portfolio; 9.4.8.3. Financial Overview; 9.4.8.4. Business Strategies and Development; 9.4.9. Cerba research; 9.4.9.1. Company Overview; 9.4.9.2. Product Portfolio; 9.4.9.3. Financial Overview; 9.4.9.4. Business Strategies and Development; 9.4.10. Alpha Laboratories Ltd; 9.4.10.1. Company Overview; 9.4.10.2. Product Portfolio; 9.4.10.3. Financial Overview; 9.4.10.4. Business Strategies and Development; 9.4.11. Marken SAS; 9.4.11.1. Company Overview; 9.4.11.2. Product Portfolio; 9.4.11.3. Financial Overview; 9.4.11.4. Business Strategies and Development; 9.4.12. Clinigen; 9.4.12.1. Company Overview; 9.4.12.2. Product Portfolio; 9.4.12.3. Financial Overview; 9.4.12.4. Business Strategies and Development
10. Appendix: 10.1. Research Methodology; 10.2. Report Assumptions; 10.3. Acronyms and Abbreviations

Research Assistance

US: 800.298.5699

Int'l: +1.240.747.3093

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Clinical Trial Kits Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Clinical Trial Kits Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Outsourced Clinical Trials & Formulation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Clinical Trial Management System Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Europe, Asia-Pacific, South America and Middle East & Africa Electric Vehicle Market

Clinical Rollators Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Clinical Chemistry Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Sulfur Hexafluoride Market, By Grade (Electronic Grade, UHP Grade, and Standard Grade), By Application (Power & Energy, Medical, Metal Manufacturing, Electronics, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Research Assistance

Other tasks